Skip to content
REPORTWIRE NEWSROOM
Breaking
Breaking News

MRTX Stock Price | Mirati Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

MRTX Stock Price | Mirati Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

[ad_1]

Mirati Therapeutics Inc.

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm’s products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA.

[ad_2]

Source link

ReportWire

ReportWire newsroom contributor.

Related Stories